State University of New York at Buffalo
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, State University of New York at Buffalo sits in the top decile of US sponsors by registered trial count (#135 of 15,742 sponsors by registered trial count).
State University of New York at Buffalo: 243 sponsored US clinical trials, 52 recruiting.
State University of New York at Buffalo sponsors 243 registered US clinical trials on ClinicalTrials.gov, 52 of them currently recruiting, and 156 completed. 19 of these trials are in Phase 3-4 (later-stage) and 26 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Multiple Sclerosis, with 4 trials.
Top-decile sponsor footprint
State University of New York at Buffalo ranks in the top decile of sponsors by registered trial count (#135 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
156 of 172 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
243 total, page 1 of 5
Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia
NCT07512687
Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
NCT07641361
Impact of VNS With Rehab on Gait Post-Stroke
NCT07643337
PAIRS: Friend-Based AISA Intervention
NCT07433270
CGM-Enhanced DPP to Prevent Type 2 Diabetes in Adults With Prediabetes
NCT07140848
Comparison of Root Canal Desinfection Protocols
NCT07439614
Neuromodulation to Improve Grasping Function After SCI
NCT07433959
Speech Learning and Speech Production in Parkinson's Disease
NCT07403539
Prevention of Postpartum Smoking Relapse and Related Health Consequences by Breastfeeding Promotion
NCT07661550
Developmental Trajectories of Reinforcer Pathology and Childhood Obesity
NCT07229508
Photoacoustic Imaging of Foot Wound
NCT07216599
Evaluation of Toothbrush Bristles
NCT07306026
Collaborative Opportunities for Reducing Alcohol and Sexual Violence Together
NCT07261722
Community Pharmacies as Social Determinant of Health Navigators
NCT07278401
Cessation of Dual Use of Cigarettes and E-cigarettes During Pregnancy
NCT07124702
Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)
NCT06463743
Group Recreation to Enhance Function Aging
NCT07050589
Pain Control Alternatives in Pediatric Patients With Distal Radius Fractures
NCT07120763
Air Pollution and Physical Activity Study
NCT06386055
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
NCT07048574
Cardiovascular Risk Reduction for Adults With Food Insecurity Using Structured Incentives
NCT06818669
A Positive Food Parenting Intervention to Promote Healthy Growth in Children at Risk for Obesity
NCT06981429
Neuromodulation After Spinal Cord Injury to Improve Limb Function
NCT06815601
Remote vs. In-Person Study Evaluation (RISE) Trials: RISE Above Smoking (Trial 1)
NCT06822049
Vaping and Smoking Project in People With Schizophrenia
NCT06944847
IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer
NCT06206941
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
NCT00682695
PICU-related Sleep and Circadian Dysregulation Pilot Study
NCT06505447
Predicting Responses to Exhausting, Prolonged, And Repeated Exercise Demands (PREPARED) for Heat
NCT06475339
Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination with Sunitinib in Patients with TKIs-resistant RCC
NCT06222593
Project ASTHMA - Aligning With Schools To Help Manage Asthma and Improve Outcomes
NCT06539312
Exercise Reset for Concussion in a Military Environment
NCT05498038
Neuromodulation and Neuroimaging in Older Children With Mild Traumatic Brain Injury
NCT05762796
The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses
NCT06128915
Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
NCT06172283
The Early Childhood Friendship Project - Phase 3
NCT05908461
Benefits of Nicotinamide Riboside Upon Cognition and Sleep
NCT05500170
Cannabis Use and Outcomes in Black and White Patients With Cancer
NCT06037681
Vaping and Smoking Withdrawal Project
NCT05772845
PUSH-IT Continuing Enteral Feeds for Tracheostomy
NCT05906472
EPPIC: Easing Pelvic Pain Interventions Clinical Research Program
NCT05127616
Comparison of Intraocular Pressure Measurement With the Novel TonoVera Device With Other Commonly Used Devices
NCT05523622
EMS Providers' Health Initiative Study
NCT05153759
A Pilot and Feasibility Study of a Dietary Intervention With Low-protein Meals in Cancer Patients Receiving Immunotherapies
NCT05356182
Inhaled Isopropyl Alcohol for Treatment of Nausea
NCT05418244
A Pilot, Feasibility Study of Intermittent Caloric Restriction Plus Plant-based Diet in Cancer Patients Receiving Chemotherapy
NCT05359848
ROSE-Longitudinal Assessment With Neuroimaging
NCT05089331
Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database
NCT02897908
Maternal Smoking Cessation and Pediatric Obesity Prevention
NCT03514602
Krabbe Disease Global Patient Registry
NCT02993796
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 11 |
| Phase 2 | 15 |
| Phase 3 | 7 |
| Phase 4 | 12 |
What is open in the State University of New York at Buffalo pipeline
52 recruiting of 243 indexed (21% open); 156 completed (64%).
Phase mix: 19 late (III/IV) vs 26 early (I/II) (balanced across stages).
Top condition: Multiple Sclerosis (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
State University of New York at Buffalo: open-pipeline peers nationwide
Peers matched on 243 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
State University of New York at Buffalo sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 243 trials (± recruiting share)
- Shire · 245 trials · 0% recruiting
- University of Cincinnati · 245 trials · 14% recruiting
- University of Massachusetts, Worcester · 240 trials · 13% recruiting
- Incyte Corporation · 239 trials · 15% recruiting
Sponsors near 21% open enrollment (± trial volume)
- Axsome Therapeutics · 21% recruiting · 28 trials
- GOG Foundation · 21% recruiting · 14 trials
- Kettering Health Network · 21% recruiting · 14 trials
- LifeBridge Health · 21% recruiting · 14 trials
Related
What to do with this State University of New York at Buffalo page
243 registered trials is a research-attention snapshot, not an endorsement of State University of New York at Buffalo or any single study.
- 52 of State University of New York at Buffalo's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Multiple Sclerosis is the condition State University of New York at Buffalo studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Multiple Sclerosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
State University of New York at Buffalo pipeline card: 243 registered trials from official public datasets.Report a data error.